Table 1 Patient demographics
Age at Diagnosis (years) | |
Median (range) | 54 (21–90+) |
Sex, n (%) | |
Male | 28 (59.6%) |
Female | 19 (40.4%) |
Follow-Up (months) | |
Median (range) | 98 (3-555) |
Sample Type, n (%) | |
Primary | 40 (85.1%) |
Recurrent | 7 (14.9%) |
Hyams Grade, n (%) | |
I | 7 (14.9%) |
II | 22 (46.8%) |
III | 12 (25.5%) |
IV | 5 (10.6%) |
Unknown | 1 (2.1%) |
Modified Kadish Stage, n (%) | |
A | 4 (8.5%) |
B | 4 (8.5%) |
C | 34 (72.3%) |
D | 5 (10.6%) |
Dulgerov Stage Sample, n (%) | |
T1 | 8 (17.0%) |
T2 | 13 (27.7%) |
T3 | 12 (25.5%) |
T4 | 10 (21.3%) |
Unknown | 4 (8.5%) |
Presenting Symptoms, n (%) | |
Dural infiltration | 18 (38.3%) |
Orbital involvement | 3 (6.4%) |
Nasal obstruction | 24 (51.1%) |
Rhinorrhea | 9 (19.1%) |
Epistaxis | 20 (42.6%) |
Anosmia | 11 (23.4%) |
Headache | 8 (17.0%) |
Epiphora | 1 (2.1%) |
Diplopia | 1 (2.1%) |
Pain | 8 (17.0%) |